Karyopharm Therapeutics

KPTI58

Penny Stock

$0.83arrow_drop_down0.03%-$0.00

Penny Stock

KPTI58

$0.83

arrow_drop_down0.03%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.91
Prev. Close	$0.92
EPS	-1.05
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$110.91M
PE Ratio	-

	LOW	HIGH
Day Range	0.87	0.94
52 Week Range	0.61	1.95

Ratios

Revenue	-





EPS	-1.05

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc (KPTI) is a pharmaceutical company that focuses on the discovery and development of novel drugs to treat cancer and other diseases. The company's lead product candidate is selinexor, which is a first-in-class, oral selective inhibitor of nuclear export (SINE) compound. Selinexor has shown promising results in clinical trials and has the potential to become a game-changer in the treatment of multiple cancers. Karyopharm is also developing several other SINE compounds targeting different disease indications.

Karyopharm Therapeutics Inc's stock price history shows that the company has experienced significant volatility over the years. The stock has had both periods of strong growth and periods of decline. It is important for investors to carefully analyze the company's financials and news before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Richard A. Paulson M.B.A.
Headquarters: Newton
Employees: 385
Exchange: NASDAQ

add Karyopharm Therapeutics to watchlist

Keep an eye on Karyopharm Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Karyopharm Therapeutics 's (KPTI) price per share?

The current price per share for Karyopharm Therapeutics (KPTI) is $0.84. The stock has seen a price change of -$0 recently, indicating a -0.04% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Karyopharm Therapeutics (KPTI)?

For Karyopharm Therapeutics (KPTI), the 52-week high is $1.95, which is 132.97% from the current price. The 52-week low is $0.62, the current price is 35.66% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Karyopharm Therapeutics (KPTI) a growth stock?

Karyopharm Therapeutics (KPTI) has shown an average price growth of -3.55% over the past three years. It has received a score of 12 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Karyopharm Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Karyopharm Therapeutics (KPTI) stock price performance year to date (YTD)?

As of the latest data, Karyopharm Therapeutics (KPTI) has a year-to-date price change of -7.12%. Over the past month, the stock has experienced a price change of -1.53%. Over the last three months, the change has been 3.59%. Over the past six months, the figure is -23.21%. Looking at a longer horizon, the five-year price change stands at -94.55%.

help

Is Karyopharm Therapeutics (KPTI) a profitable company?

Karyopharm Therapeutics (KPTI) has a net income of -$143.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -67.77% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $141.09M. Operating income is noted at -$129.54M. Furthermore, the EBITDA is -$125.63M.

help

What is the market capitalization of Karyopharm Therapeutics (KPTI)?

Karyopharm Therapeutics (KPTI) has a market capitalization of $104.93M. The average daily trading volume is 0.84, indicating the stock's liquidity and investor engagement.